Freya Easton
Private Equity Investor bei SV Health Investors LLP
Ursprung des Netzwerks ersten Grades von Freya Easton
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Oxford
216
| College/University | Other Consumer Services | 216 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London.
32
| Holding Company | Investment Managers | 32 |
Farallon Capital Management LLC
 Farallon Capital Management LLC Investment ManagersFinance Farallon Capital Management LLC (Farallon) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1986 and is a wholly-owned subsidiary of Farallon Capital Management LP. Farallon provides administrative services and discretionary investment management services to private investment funds, the securities of which are offered to investors on a private placement basis; and to separately managed accounts for institutions such as endowments, foundations, charitable organizations and state and municipal government entities.
6
| Subsidiary | Investment Managers | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Freya Easton
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Cambridge | College/University | Graduate Degree Masters Business Admin Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Director/Board Member Founder Chief Executive Officer | |
SYSTEMIQ Ltd.
 SYSTEMIQ Ltd. Investment ManagersFinance SystemIQ Ltd (SystemIQ ) is a venture capital firm founded by Martin Stuchtey and Jeremy Oppenheim in 2016. The firm Headquartered in United Kingdom. | Investment Managers | Private Equity Analyst Private Equity Analyst Private Equity Analyst | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Loqus23 Therapeutics Ltd.
 Loqus23 Therapeutics Ltd. BiotechnologyHealth Technology Loqus23 Therapeutics Ltd.engages in research and development of biotechnology. The company was founded on March 29, 2019 and is headquartered in in Reading, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
Cellinta Ltd.
 Cellinta Ltd. Investment ManagersFinance Cellinta Ltd. operates as a biotechnology firm. The company was founded on August 16, 2019 and is headquartered in Reading, the United Kingdom. | Investment Managers | Director/Board Member Director/Board Member | |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Founder Founder | |
| Enara Bio Ltd. | Biotechnology | Chief Executive Officer Founder | |
SV Health Managers LLP
 SV Health Managers LLP Investment ManagersFinance SV Health Managers LLP (SVHM) is the investment management subsidiary of SV Life Sciences Advisers LLP in the UK. Established in 2005, the firm was formerly known as SV Life Sciences Managers LLP and changed their name to SV Health Managers LLP in 2017. Based in London, the firm manages the International Biotechnology Trust plc (LSE: IBT), an investment trust vehicle listed on the London Stock Exchange into which corporate and private investors may invest. | Investment Managers | Chief Executive Officer Portfolio Manager-Equities | |
Oxford University Innovation Ltd.
 Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Eyebiotech Ltd.
 Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Biotechnology | Director/Board Member Chairman | |
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Zarodex Therapeutics Ltd.
 Zarodex Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Zarodex Therapeutics Ltd. engages in the research and experimental development on biotechnology. The company was founded on July 26, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Ervaxx Ltd.
 Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Alchemab Therapeutics Ltd.
 Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Alchemab Therapeutics Ltd. engages in developing of antibodies. It focuses on discovering and developing novel therapeutics for patients. The company was founded in 2019 and is headquartered in Kings Cross, the Unite Kingdom. | Biotechnology | Director/Board Member Founder | |
Cybele Therapeutics Ltd.
 Cybele Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Cybele Therapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 23, 2019 and is headquartered in Reading, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst Private Equity Investor | |
Mestag Therapeutics Ltd.
 Mestag Therapeutics Ltd. Financial ConglomeratesFinance Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom. | Financial Conglomerates | Director/Board Member Founder | |
Credit Suisse Securities (Europe) Ltd.
 Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
Morgan Stanley & Co. International Plc
 Morgan Stanley & Co. International Plc Investment Banks/BrokersFinance Morgan Stanley & Co. International Plc (MSCI) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Morgan Stanley Investments (UK), ultimately held by Morgan Stanley (NYSE: MS) in the US. MSCI provides a range of brokerage services to corporations, governments and financial institutions. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree | |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
Endlyz Therapeutics, Inc.
 Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Biotechnology | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
TDR Capital LLP
 TDR Capital LLP Investment ManagersFinance TDR Capital LLP (TDR Capital) is a private equity subsidiary of Tudor Investment Corp. founded in 2002 by Manjit Dale and Stephen James Robertson. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Analyst | |
| University of Western Sydney | College/University | Masters Business Admin | |
| CHINA NEW HIGHER EDUCATION GROUP LIMITED | Miscellaneous Commercial Services | Director/Board Member | |
Symprove Ltd.
 Symprove Ltd. Food RetailRetail Trade Symprove Ltd. is a British company that offers a unique gut health supplement called Daily Essential, which contains billions of live and active bacteria for gut support. The company is based in Farnham, UK and was founded in 2002 by Barry Smith and Barry Edward Smith. The product comes in three different flavors and is gluten and dairy-free. With over 100K happy customers, Symprove's scientifically proven product is known to boost beneficial bacteria and improve gut health. Mike Butler has been the CEO of the company since 2010. | Food Retail | Director/Board Member | |
Cambridge Enterprise Ltd.
 Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Investment Managers | Private Equity Investor | |
| University of Porto | College/University | Undergraduate Degree | |
Ascenti Health Ltd.
 Ascenti Health Ltd. Medical/Nursing ServicesHealth Services Ascenti Health Ltd. is a healthcare provider that offers physiotherapy and occupational health services to more than 38 NHS organizations and 357 private businesses. The company is based in Fareham, UK, and has subsidiaries in the United Kingdom. The British company is dedicated to providing the best services possible and encourages feedback from its clients. The company's website provides information on physiotherapy and wellbeing, including finding a therapist in your area and learning about symptoms and treatments. Ascenti Health was founded in 1996 and is led by CEO Stephanie Elizabeth Squire Dobrikova. | Medical/Nursing Services | Director/Board Member | |
HexagonFab Ltd.
 HexagonFab Ltd. Medical SpecialtiesHealth Technology HexagonFab Ltd. develops biological sensors that enable rapid and cost-effective detection of biological substances such as proteins, DNA, or small molecules. The company is based in Cambridge, UK. The British company's award-winning technology eliminates the need for lengthy and expensive lab processes. The sensors can measure Antibody Antigen kinetics with the HexagonFab Bolt. The company was founded by Ruizhi Wang, Christoph von Bieberstein, Stephan Hofmann. | Medical Specialties | Director/Board Member | |
Cerevance, Inc.
 Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Medical Specialties | Director/Board Member | |
AviadoBio Ltd.
 AviadoBio Ltd. BiotechnologyHealth Technology AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Shanghai University of Finance & Economics
 Shanghai University of Finance & Economics Other Consumer ServicesConsumer Services Shanghai University of Finance and Economics engages in the provision of educational services. It offers courses under the following school and departments: business, accountancy, finance, international business administration, economics, public economics and administration, humanities, law, information management and engineering, statistics, foreign languages, mathematics, international cultural exchange, professional and international education and continuing education. The company was founded in 1917 and is headquartered in Shanghai, China. | College/University | Doctorate Degree | |
| Huiyue Development Strategy Co. Ltd. | Founder | ||
| Australian Institute of Banking & Finance | Corporate Officer/Principal | ||
Yango Intelligent Life Service Group Co., Ltd.
 Yango Intelligent Life Service Group Co., Ltd. Real Estate DevelopmentFinance Yango Intelligent Life Service Group Co., Ltd. engages in property management and parking garage operation services. It provides diversified services in two business segments: property management services and commercial property operational and management services. The company was founded on July 29, 2020 and is headquartered in Shanghai, China. | Real Estate Development | Director/Board Member | |
| University of West London | College/University | Undergraduate Degree | |
| Guangdong Investment Development Promotion Association | Corporate Officer/Principal |
Statistik
International
| Vereinigtes Königreich | 27 |
| Vereinigte Staaten | 14 |
| China | 6 |
| Schweiz | 3 |
| Australien | 3 |
Sektoral
| Health Technology | 16 |
| Finance | 14 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Retail Trade | 2 |
Operativ
| Director/Board Member | 140 |
| Undergraduate Degree | 73 |
| Private Equity Investor | 67 |
| Corporate Officer/Principal | 63 |
| Analyst-Equity | 35 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Kate Bingham | 31 |
| Houman Ashrafian | 22 |
| Linda Maxwell | 17 |
| Ruth McKernan | 16 |
| Allan W. May | 16 |
| Tsz Kit Pang | 16 |
| Kevin Pojasek | 14 |
| Hamish Alan Cameron | 14 |
| Graham J. Boulnois | 14 |
| Anne Prener | 14 |
| Aaron Sandoski | 12 |
| Brett K. Haumann | 11 |
| Charles Roberts | 10 |
| Sana Fathima | 10 |
| Dmitry Kuzmin | 9 |
- Börse
- Insiders
- Freya Easton
- Unternehmensverbindungen
